Background and Aims: Modern electronic (e)-cigarettes have only been available since 2003. Nothing is known of the long-term health consequences of inhaling e-cigarette vapor (EV). We hypothesized that daily inhalation of heated and aerosolized propylene glycol, glycerin and nicotine would lead to repetitive injury to lung airways and parenchyma and culminate in increased airway resistance and decreased lung compliance.
Methods: Male C57BL/6 mice, 6-8 weeks old, were exposed for 1 h daily to: 1. EV containing nicotine, 2. vehicle no-nicotine EV (VEH), or 3. room air only (AIR). After six months of exposure via the InExpose system (SciReq), mice were sedated, trached and attached to the flexiVent mouse ventilator (SciReq). Lung mechanics scans were conducted, and airway responsiveness assessed with inhaled methacholine (MCH) challenge at 0, 6, 12, and 24 mg/mL.
Results: There were no significant differences between baseline lung parameters in the three groups. There were significant differences between EV and AIR for Respiratory System Elastance (Ers), Tissue Damping (G), and Tissue Elastance (H) at 24 mg/mL of MCH. EV vs VEH was also significantly different for Tissue Elastance (H) at 24 MCH. There was a significant difference between AIR vs VEH and VEH vs EV for Newtonian Resistance (Rn), a measure of central airway resistance, at 12 MCH but not at higher doses of MCH.
Conclusion:
Our data suggest that airway resistance and lung compliance changes occur with chronic exposure to key components of ecigarettes -nicotine, propylene glycol and glycerin. This indicates that eliquid flavors are unlikely to be the sole causes of lung toxicity, especially in the setting of long-term daily e-cigarette use. 
Methods:
We conducted experiments using arundic acid, a blocker of astrocytic activation, in the isolated medulla-spinal cord preparation of newborn rats, which is ideal for the study of the purely central mechanism of respiratory control. Neural respiratory output was recorded from ventral roots of the 4th cervical cord. Firstly, we compared neural respiratory frequency while superfusing preparations with normoxic (95% O 2 , 5% CO 2 ) artificial cerebrospinal fluid before and after administration of arundic acid (100 and 500 μM). Secondly, hypoxic responses were tested without and with two doses of arundic acid, by replacing the superfusates that were saturated with hypoxic (95% N 2 , 5% CO 2 ) gas mixture to briefly load hypoxia.
Results: Without arundic acid, hypoxia increased respiratory frequency. A low concentration (100 μM) arundic acid did not appreciably affect either respiratory output in a normoxic condition or a hypoxic respiratory response. However, a high concentration (500 μM) arundic acid decreased respiratory frequency in a normoxic condition, and suppressed a hypoxia-induced increase in respiratory frequency. 
Conclusion

